HEADER TRANSFERASE/TRANSFERASE INHIBITOR 24-DEC-14 4RZW TITLE CRYSTAL STRUCTURE OF BRAF (R509H) KINASE DOMAIN BOUND TO AZ628 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: PROTEIN KINASE DOMAIN RESIDUES 443-723; COMPND 5 SYNONYM: PROTO-ONCOGENE B-RAF, P94, V-RAF MURINE SARCOMA VIRAL COMPND 6 ONCOGENE HOMOLOG B1; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.WU,E.GAVATHIOTIS REVDAT 2 20-SEP-23 4RZW 1 REMARK SEQADV REVDAT 1 10-AUG-16 4RZW 0 JRNL AUTH Z.KAROULIA,Y.WU,T.A.AHMED,X.QISHENG,J.BOLLARD,C.KREPLER, JRNL AUTH 2 X.WU,C.ZHANG,G.BOLLAG,M.HERLYM,J.A.FAGIN,A.LUJAMBIO, JRNL AUTH 3 E.GAVATHIOTIS,P.I.POULIKAKOS JRNL TITL AN INTEGRATED MODEL OF RAF INHIBITOR ACTION PREDICTS JRNL TITL 2 INHIBITOR ACTIVITY AGAINST ONCOGENIC BRAF SIGNALING JRNL REF CANCER CELL V. 30 1 2016 JRNL REFN ISSN 1535-6108 REMARK 2 REMARK 2 RESOLUTION. 3.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: DEV_1819) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.76 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 7496 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.249 REMARK 3 R VALUE (WORKING SET) : 0.247 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.590 REMARK 3 FREE R VALUE TEST SET COUNT : 344 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.7668 - 4.3999 0.99 3650 182 0.2349 0.2433 REMARK 3 2 4.3999 - 3.4930 0.99 3502 162 0.2653 0.3474 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.420 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.180 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4190 REMARK 3 ANGLE : 0.888 5652 REMARK 3 CHIRALITY : 0.034 605 REMARK 3 PLANARITY : 0.004 717 REMARK 3 DIHEDRAL : 15.326 1596 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 27.0244 127.7454 79.6063 REMARK 3 T TENSOR REMARK 3 T11: 0.3849 T22: 0.4985 REMARK 3 T33: 0.4934 T12: -0.0025 REMARK 3 T13: -0.0558 T23: -0.0378 REMARK 3 L TENSOR REMARK 3 L11: 0.5984 L22: 2.6719 REMARK 3 L33: 1.2298 L12: 0.1202 REMARK 3 L13: -0.4118 L23: -0.6190 REMARK 3 S TENSOR REMARK 3 S11: 0.0048 S12: 0.1215 S13: -0.0166 REMARK 3 S21: 0.0832 S22: 0.0382 S23: 0.0812 REMARK 3 S31: -0.0571 S32: 0.0282 S33: -0.0420 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4RZW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-DEC-14. REMARK 100 THE DEPOSITION ID IS D_1000088003. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-FEB-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : DIAMOND REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7524 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.493 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.20000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.67000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3C4C REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.0, 0.2 M MG(NO3)2, REMARK 280 18% (W/V) PEG3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 43.03850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 57.41150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 43.03850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 57.41150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 443 REMARK 465 ARG A 444 REMARK 465 ASP A 445 REMARK 465 SER A 446 REMARK 465 SER A 447 REMARK 465 LEU A 597 REMARK 465 ALA A 598 REMARK 465 THR A 599 REMARK 465 VAL A 600 REMARK 465 LYS A 601 REMARK 465 SER A 602 REMARK 465 ARG A 603 REMARK 465 TRP A 604 REMARK 465 SER A 605 REMARK 465 GLY A 606 REMARK 465 SER A 607 REMARK 465 HIS A 608 REMARK 465 GLN A 609 REMARK 465 PHE A 610 REMARK 465 GLU A 611 REMARK 465 GLN A 612 REMARK 465 LEU A 613 REMARK 465 SER A 614 REMARK 465 MET A 627 REMARK 465 GLN A 628 REMARK 465 ASP A 629 REMARK 465 SER A 630 REMARK 465 LEU A 721 REMARK 465 SER A 722 REMARK 465 GLY A 723 REMARK 465 ARG B 443 REMARK 465 ARG B 444 REMARK 465 ASP B 445 REMARK 465 SER B 446 REMARK 465 SER B 447 REMARK 465 GLY B 596 REMARK 465 LEU B 597 REMARK 465 ALA B 598 REMARK 465 THR B 599 REMARK 465 VAL B 600 REMARK 465 LYS B 601 REMARK 465 SER B 602 REMARK 465 ARG B 603 REMARK 465 TRP B 604 REMARK 465 SER B 605 REMARK 465 GLY B 606 REMARK 465 SER B 607 REMARK 465 HIS B 608 REMARK 465 GLN B 609 REMARK 465 PHE B 610 REMARK 465 GLU B 611 REMARK 465 GLN B 612 REMARK 465 LEU B 613 REMARK 465 SER B 614 REMARK 465 GLN B 628 REMARK 465 ASP B 629 REMARK 465 SER B 630 REMARK 465 SER B 722 REMARK 465 GLY B 723 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 468 -33.68 -131.11 REMARK 500 ARG A 575 -5.73 68.37 REMARK 500 ASP A 576 63.59 -152.61 REMARK 500 ASP A 587 7.91 57.99 REMARK 500 VAL B 459 -158.06 -87.66 REMARK 500 GLN B 461 58.00 34.37 REMARK 500 TRP B 476 97.93 -161.21 REMARK 500 LEU B 485 59.00 -105.94 REMARK 500 THR B 546 108.99 -53.48 REMARK 500 ARG B 575 -4.21 69.11 REMARK 500 ASP B 576 62.26 -153.45 REMARK 500 ASP B 587 6.34 57.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B1E A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B1E B 801 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4RZV RELATED DB: PDB DBREF 4RZW A 443 723 UNP P15056 BRAF_HUMAN 443 723 DBREF 4RZW B 443 723 UNP P15056 BRAF_HUMAN 443 723 SEQADV 4RZW HIS A 509 UNP P15056 ARG 509 ENGINEERED MUTATION SEQADV 4RZW ALA A 543 UNP P15056 ILE 543 ENGINEERED MUTATION SEQADV 4RZW SER A 544 UNP P15056 ILE 544 ENGINEERED MUTATION SEQADV 4RZW LYS A 551 UNP P15056 ILE 551 ENGINEERED MUTATION SEQADV 4RZW ARG A 562 UNP P15056 GLN 562 ENGINEERED MUTATION SEQADV 4RZW ASN A 588 UNP P15056 LEU 588 ENGINEERED MUTATION SEQADV 4RZW SER A 630 UNP P15056 LYS 630 ENGINEERED MUTATION SEQADV 4RZW GLU A 667 UNP P15056 PHE 667 ENGINEERED MUTATION SEQADV 4RZW SER A 673 UNP P15056 TYR 673 ENGINEERED MUTATION SEQADV 4RZW ARG A 688 UNP P15056 ALA 688 ENGINEERED MUTATION SEQADV 4RZW SER A 706 UNP P15056 LEU 706 ENGINEERED MUTATION SEQADV 4RZW ARG A 709 UNP P15056 GLN 709 ENGINEERED MUTATION SEQADV 4RZW GLU A 713 UNP P15056 SER 713 ENGINEERED MUTATION SEQADV 4RZW GLU A 716 UNP P15056 LEU 716 ENGINEERED MUTATION SEQADV 4RZW GLU A 720 UNP P15056 SER 720 ENGINEERED MUTATION SEQADV 4RZW SER A 722 UNP P15056 PRO 722 ENGINEERED MUTATION SEQADV 4RZW GLY A 723 UNP P15056 LYS 723 ENGINEERED MUTATION SEQADV 4RZW HIS B 509 UNP P15056 ARG 509 ENGINEERED MUTATION SEQADV 4RZW ALA B 543 UNP P15056 ILE 543 ENGINEERED MUTATION SEQADV 4RZW SER B 544 UNP P15056 ILE 544 ENGINEERED MUTATION SEQADV 4RZW LYS B 551 UNP P15056 ILE 551 ENGINEERED MUTATION SEQADV 4RZW ARG B 562 UNP P15056 GLN 562 ENGINEERED MUTATION SEQADV 4RZW ASN B 588 UNP P15056 LEU 588 ENGINEERED MUTATION SEQADV 4RZW SER B 630 UNP P15056 LYS 630 ENGINEERED MUTATION SEQADV 4RZW GLU B 667 UNP P15056 PHE 667 ENGINEERED MUTATION SEQADV 4RZW SER B 673 UNP P15056 TYR 673 ENGINEERED MUTATION SEQADV 4RZW ARG B 688 UNP P15056 ALA 688 ENGINEERED MUTATION SEQADV 4RZW SER B 706 UNP P15056 LEU 706 ENGINEERED MUTATION SEQADV 4RZW ARG B 709 UNP P15056 GLN 709 ENGINEERED MUTATION SEQADV 4RZW GLU B 713 UNP P15056 SER 713 ENGINEERED MUTATION SEQADV 4RZW GLU B 716 UNP P15056 LEU 716 ENGINEERED MUTATION SEQADV 4RZW GLU B 720 UNP P15056 SER 720 ENGINEERED MUTATION SEQADV 4RZW SER B 722 UNP P15056 PRO 722 ENGINEERED MUTATION SEQADV 4RZW GLY B 723 UNP P15056 LYS 723 ENGINEERED MUTATION SEQRES 1 A 281 ARG ARG ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY SEQRES 2 A 281 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE SEQRES 3 A 281 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA SEQRES 4 A 281 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN SEQRES 5 A 281 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS SEQRES 6 A 281 THR HIS HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER SEQRES 7 A 281 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU SEQRES 8 A 281 GLY SER SER LEU TYR HIS HIS LEU HIS ALA SER GLU THR SEQRES 9 A 281 LYS PHE GLU MET LYS LYS LEU ILE ASP ILE ALA ARG GLN SEQRES 10 A 281 THR ALA ARG GLY MET ASP TYR LEU HIS ALA LYS SER ILE SEQRES 11 A 281 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS SEQRES 12 A 281 GLU ASP ASN THR VAL LYS ILE GLY ASP PHE GLY LEU ALA SEQRES 13 A 281 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU SEQRES 14 A 281 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL SEQRES 15 A 281 ILE ARG MET GLN ASP SER ASN PRO TYR SER PHE GLN SER SEQRES 16 A 281 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET SEQRES 17 A 281 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP SEQRES 18 A 281 GLN ILE ILE GLU MET VAL GLY ARG GLY SER LEU SER PRO SEQRES 19 A 281 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ARG MET SEQRES 20 A 281 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP SEQRES 21 A 281 GLU ARG PRO SER PHE PRO ARG ILE LEU ALA GLU ILE GLU SEQRES 22 A 281 GLU LEU ALA ARG GLU LEU SER GLY SEQRES 1 B 281 ARG ARG ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY SEQRES 2 B 281 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE SEQRES 3 B 281 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA SEQRES 4 B 281 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN SEQRES 5 B 281 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS SEQRES 6 B 281 THR HIS HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER SEQRES 7 B 281 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU SEQRES 8 B 281 GLY SER SER LEU TYR HIS HIS LEU HIS ALA SER GLU THR SEQRES 9 B 281 LYS PHE GLU MET LYS LYS LEU ILE ASP ILE ALA ARG GLN SEQRES 10 B 281 THR ALA ARG GLY MET ASP TYR LEU HIS ALA LYS SER ILE SEQRES 11 B 281 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS SEQRES 12 B 281 GLU ASP ASN THR VAL LYS ILE GLY ASP PHE GLY LEU ALA SEQRES 13 B 281 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU SEQRES 14 B 281 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL SEQRES 15 B 281 ILE ARG MET GLN ASP SER ASN PRO TYR SER PHE GLN SER SEQRES 16 B 281 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET SEQRES 17 B 281 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP SEQRES 18 B 281 GLN ILE ILE GLU MET VAL GLY ARG GLY SER LEU SER PRO SEQRES 19 B 281 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ARG MET SEQRES 20 B 281 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP SEQRES 21 B 281 GLU ARG PRO SER PHE PRO ARG ILE LEU ALA GLU ILE GLU SEQRES 22 B 281 GLU LEU ALA ARG GLU LEU SER GLY HET B1E A 801 34 HET B1E B 801 34 HETNAM B1E 3-(2-CYANOPROPAN-2-YL)-N-{4-METHYL-3-[(3-METHYL-4-OXO- HETNAM 2 B1E 3,4-DIHYDROQUINAZOLIN-6-YL)AMINO]PHENYL}BENZAMIDE FORMUL 3 B1E 2(C27 H25 N5 O2) HELIX 1 1 PRO A 453 ILE A 457 5 5 HELIX 2 2 THR A 491 ARG A 506 1 16 HELIX 3 3 LEU A 537 HIS A 542 1 6 HELIX 4 4 GLU A 549 LYS A 570 1 22 HELIX 5 5 LYS A 578 ASN A 580 5 3 HELIX 6 6 ALA A 621 ARG A 626 1 6 HELIX 7 7 SER A 634 GLY A 652 1 19 HELIX 8 8 ASN A 661 ARG A 671 1 11 HELIX 9 9 ASP A 677 VAL A 681 5 5 HELIX 10 10 PRO A 686 LEU A 697 1 12 HELIX 11 11 LYS A 700 ARG A 704 5 5 HELIX 12 12 SER A 706 ARG A 719 1 14 HELIX 13 13 THR B 491 ARG B 506 1 16 HELIX 14 14 SER B 536 HIS B 542 1 7 HELIX 15 15 GLU B 549 LYS B 570 1 22 HELIX 16 16 GLU B 586 ASN B 588 5 3 HELIX 17 17 ALA B 621 ARG B 626 1 6 HELIX 18 18 SER B 634 GLY B 652 1 19 HELIX 19 19 ASN B 661 GLY B 672 1 12 HELIX 20 20 ASP B 677 VAL B 681 5 5 HELIX 21 21 PRO B 686 LEU B 697 1 12 HELIX 22 22 SER B 706 GLU B 720 1 15 SHEET 1 A 5 THR A 458 GLY A 464 0 SHEET 2 A 5 THR A 470 LYS A 475 -1 O VAL A 471 N GLY A 464 SHEET 3 A 5 ASP A 479 MET A 484 -1 O MET A 484 N THR A 470 SHEET 4 A 5 ALA A 526 GLN A 530 -1 O THR A 529 N ALA A 481 SHEET 5 A 5 PHE A 516 SER A 520 -1 N SER A 520 O ALA A 526 SHEET 1 B 3 GLY A 534 SER A 536 0 SHEET 2 B 3 ILE A 582 HIS A 585 -1 O LEU A 584 N SER A 535 SHEET 3 B 3 THR A 589 ILE A 592 -1 O LYS A 591 N PHE A 583 SHEET 1 C 5 ARG B 462 SER B 465 0 SHEET 2 C 5 THR B 470 LYS B 475 -1 O VAL B 471 N ILE B 463 SHEET 3 C 5 ASP B 479 MET B 484 -1 O VAL B 480 N GLY B 474 SHEET 4 C 5 ALA B 526 GLN B 530 -1 O ILE B 527 N LYS B 483 SHEET 5 C 5 PHE B 516 SER B 520 -1 N SER B 520 O ALA B 526 SHEET 1 D 2 ILE B 582 HIS B 585 0 SHEET 2 D 2 THR B 589 ILE B 592 -1 O LYS B 591 N PHE B 583 CISPEP 1 ASN B 631 PRO B 632 0 -1.48 SITE 1 AC1 13 ALA A 481 LYS A 483 GLU A 501 LEU A 514 SITE 2 AC1 13 THR A 529 GLN A 530 TRP A 531 CYS A 532 SITE 3 AC1 13 HIS A 574 ILE A 592 GLY A 593 ASP A 594 SITE 4 AC1 13 PHE A 595 SITE 1 AC2 12 ALA B 481 LYS B 483 GLU B 501 LEU B 505 SITE 2 AC2 12 ILE B 527 THR B 529 GLN B 530 CYS B 532 SITE 3 AC2 12 ILE B 592 GLY B 593 ASP B 594 PHE B 595 CRYST1 86.077 114.823 56.444 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011618 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008709 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017717 0.00000